ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel biological therapeutics to address significant unmet need in oncology and immuno-oncology. ImmunoBiochem’s discovery engine utilizes a combination of high-throughput functional assays, mass spectrometry and AI/ML to unravel unique biology in the tumor microenvironment, particularly in the cancer cell secretome. This proprietary platform enables the discovery of novel tumor targets with unique behaviours that could be exploited with various targeted therapeutic modalities.

ImmunoBiochem Corporation logo



Event details

Date: January 8 - 10, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


18 in total